InventisBio Co Ltd

688382

Company Profile

  • Business description

    InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.

  • Contact

    No. 4, Lane 67, Li Bing Road
    Room 210
    Pilot Free Trade Zone
    Shanghai201203
    CHN

    T: +86 2150778527

    http://www.inventisbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    185

Stocks News & Analysis

stocks

Undervalued ASX share with plan to mitigate tariff risk

Shares have dropped 20% in the previous year due to concerns about tariffs.
stocks

Earnings up but shares overvalued for ASX gold miner

Higher gold prices are making a difference to the bottom line but investors overly optimistic.
stocks

Alphabet: Anthropic deal and Gemini momentum stand to deliver; Fair Value up 27%

We see faster cloud growth and improved longer-term profitability for Alphabet.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,295.8026.20-0.28%
CAC 408,216.5822.60-0.27%
DAX 4024,278.6330.15-0.12%
Dow JONES (US)47,706.65162.060.34%
FTSE 1009,696.7442.920.44%
HKSE26,346.1487.56-0.33%
NASDAQ23,827.49190.040.80%
Nikkei 22550,219.18293.14-0.58%
NZX 50 Index13,402.6611.070.08%
S&P 5006,890.9515.790.23%
S&P/ASX 2009,012.5016.30-0.18%
SSE Composite Index3,988.228.72-0.22%

Market Movers